Literature DB >> 16093355

The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.

Sang Gyun Kim1, Hyun-Ah Kim, Hyun-Soon Jong, Jung-Hyun Park, Noe Kyeong Kim, Seung Hwan Hong, Tae-You Kim, Yung-Jue Bang.   

Abstract

Although Smad2 and Smad3, critical transcriptional mediators of transforming growth factor-beta (TGF-beta) signaling, are supposed to play a role in the TGF-beta cytostatic program, it remains unclear whether TGF-beta delivers cytostatic signals through both Smads equally or through either differentially. Here, we report that TGF-beta cytostatic signals rely on a Smad3-, but not a Smad2-, dependent pathway and that the intensity of TGF-beta cytostatic signals can be modulated by changing the endogenous ratio of Smad3 to Smad2. Depleting endogenous Smad3 by RNA interference sufficiently interfered with TGF-beta cytostatic actions in various TGF-beta-sensitive cell lines, whereas raising the relative endogenous ratio of Smad3 to Smad2, by depleting Smad2, markedly enhanced TGF-beta cytostatic response. Consistently, Smad3 activation and its transcriptional activity upon TGF-beta stimulation were facilitated in Smad2-depleted cells relative to controls. Most significantly, a single event of increasing this ratio by Smad2 depletion was sufficient to restore TGF-beta cytostatic action in cells resistant to TGF-beta. These findings suggest a new important determinant of sensitivity to TGF-beta cytostatic signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093355      PMCID: PMC1237073          DOI: 10.1091/mbc.e05-01-0054

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  55 in total

Review 1.  Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.

Authors:  S J Kim; Y H Im; S D Markowitz; Y J Bang
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

Review 2.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  A new partner for inhibitory Smads.

Authors:  Kohei Miyazono
Journal:  Cytokine Growth Factor Rev       Date:  2002-02       Impact factor: 7.638

4.  Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Authors:  K Pardali; A Kurisaki; A Morén; P ten Dijke; D Kardassis; A Moustakas
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

5.  Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.

Authors:  S G Kim; S N Kim; H S Jong; N K Kim; S H Hong; S J Kim; Y J Bang
Journal:  Oncogene       Date:  2001-03-08       Impact factor: 9.867

6.  Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Authors:  E Piek; W J Ju; J Heyer; D Escalante-Alcalde; C L Stewart; M Weinstein; C Deng; R Kucherlapati; E P Bottinger; A B Roberts
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

7.  A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.

Authors:  G F Claassen; S R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

8.  Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.

Authors:  G von Gersdorff; K Susztak; F Rezvani; M Bitzer; D Liang; E P Böttinger
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

9.  Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.

Authors:  X H Feng; X Lin; R Derynck
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

Review 10.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

View more
  29 in total

1.  p38 Mitogen-activated protein kinase affects transforming growth factor-beta/Smad signaling in human dental pulp cells.

Authors:  Feng-Ming Wang; Tao Hu; Hong Tan; Xue-Dong Zhou
Journal:  Mol Cell Biochem       Date:  2006-08-22       Impact factor: 3.396

2.  Smad3 deficiency reduces neurogenesis in adult mice.

Authors:  Yu Wang; Aviva J Symes
Journal:  J Mol Neurosci       Date:  2010-02-13       Impact factor: 3.444

3.  FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells.

Authors:  Xing-Long Liu; Yu-Han Meng; Jian-Li Wang; Biao-Bing Yang; Fan Zhang; Sheng-Jian Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

4.  Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes.

Authors:  Catherine Itman; Chris Small; Michael Griswold; Ankur K Nagaraja; Martin M Matzuk; Chester W Brown; David A Jans; Kate L Loveland
Journal:  Dev Dyn       Date:  2009-07       Impact factor: 3.780

5.  Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells.

Authors:  Jiayi Yang; Reema Wahdan-Alaswad; David Danielpour
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

6.  Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55.

Authors:  H Wang; K Song; T L Krebs; J Yang; D Danielpour
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

Review 7.  Decoding the quantitative nature of TGF-beta/Smad signaling.

Authors:  David C Clarke; Xuedong Liu
Journal:  Trends Cell Biol       Date:  2008-08-15       Impact factor: 20.808

Review 8.  Roles of Smad3 in TGF-beta signaling during carcinogenesis.

Authors:  Caroline Millet; Ying E Zhang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

9.  Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.

Authors:  Xing Guo; Alejandro Ramirez; David S Waddell; Zhizhong Li; Xuedong Liu; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2008-01-01       Impact factor: 11.361

10.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.